212 related articles for article (PubMed ID: 38057661)
21. Psychiatric symptoms of frontotemporal dementia and subcortical (co-)pathology burden: new insights.
Scarioni M; Gami-Patel P; Peeters CFW; de Koning F; Seelaar H; Mol MO; van Swieten JC; ; Rozemuller AJM; Hoozemans JJM; Pijnenburg YAL; Dijkstra AA
Brain; 2023 Jan; 146(1):307-320. PubMed ID: 35136978
[TBL] [Abstract][Full Text] [Related]
22. HnRNP Pathologies in Frontotemporal Lobar Degeneration.
Jiang X; Gatt A; Lashley T
Cells; 2023 Jun; 12(12):. PubMed ID: 37371103
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneous ribonuclear protein A3 (hnRNP A3) is present in dipeptide repeat protein containing inclusions in Frontotemporal Lobar Degeneration and Motor Neurone disease associated with expansions in C9orf72 gene.
Davidson YS; Flood L; Robinson AC; Nihei Y; Mori K; Rollinson S; Richardson A; Benson BC; Jones M; Snowden JS; Pickering-Brown S; Haass C; Lashley T; Mann DMA
Acta Neuropathol Commun; 2017 Apr; 5(1):31. PubMed ID: 28431575
[TBL] [Abstract][Full Text] [Related]
24. FUS pathology in basophilic inclusion body disease.
Munoz DG; Neumann M; Kusaka H; Yokota O; Ishihara K; Terada S; Kuroda S; Mackenzie IR
Acta Neuropathol; 2009 Nov; 118(5):617-27. PubMed ID: 19830439
[TBL] [Abstract][Full Text] [Related]
25. Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis.
Tan RH; Yang Y; Kim WS; Dobson-Stone C; Kwok JB; Kiernan MC; Halliday GM
Acta Neuropathol Commun; 2017 Oct; 5(1):76. PubMed ID: 29078806
[TBL] [Abstract][Full Text] [Related]
26. Frontotemporal lobar degeneration.
Grossman M; Seeley WW; Boxer AL; Hillis AE; Knopman DS; Ljubenov PA; Miller B; Piguet O; Rademakers R; Whitwell JL; Zetterberg H; van Swieten JC
Nat Rev Dis Primers; 2023 Aug; 9(1):40. PubMed ID: 37563165
[TBL] [Abstract][Full Text] [Related]
27. Targeting RACK1 to alleviate TDP-43 and FUS proteinopathy-mediated suppression of protein translation and neurodegeneration.
Zhao B; Cowan CM; Coutts JA; Christy DD; Saraph A; Hsueh SCC; Plotkin SS; Mackenzie IR; Kaplan JM; Cashman NR
Acta Neuropathol Commun; 2023 Dec; 11(1):200. PubMed ID: 38111057
[TBL] [Abstract][Full Text] [Related]
28. Frontotemporal lobar degeneration and amyotrophic lateral sclerosis: molecular similarities and differences.
Neumann M
Rev Neurol (Paris); 2013 Oct; 169(10):793-8. PubMed ID: 24011641
[TBL] [Abstract][Full Text] [Related]
29. Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration.
Seelaar H; Klijnsma KY; de Koning I; van der Lugt A; Chiu WZ; Azmani A; Rozemuller AJ; van Swieten JC
J Neurol; 2010 May; 257(5):747-53. PubMed ID: 19946779
[TBL] [Abstract][Full Text] [Related]
30. Quantitative proton magnetic resonance spectroscopy detects abnormalities in dorsolateral prefrontal cortex and motor cortex of patients with frontotemporal lobar degeneration.
Chawla S; Wang S; Moore P; Woo JH; Elman L; McCluskey LF; Melhem ER; Grossman M; Poptani H
J Neurol; 2010 Jan; 257(1):114-21. PubMed ID: 19688233
[TBL] [Abstract][Full Text] [Related]
31. Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management.
Seltman RE; Matthews BR
CNS Drugs; 2012 Oct; 26(10):841-70. PubMed ID: 22950490
[TBL] [Abstract][Full Text] [Related]
32. Frontotemporal lobar degeneration: diversity of FTLD lesions.
Seilhean D; Bielle F; Plu I; Duyckaerts C
Rev Neurol (Paris); 2013 Oct; 169(10):786-92. PubMed ID: 24035575
[TBL] [Abstract][Full Text] [Related]
33. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration.
Cairns NJ; Bigio EH; Mackenzie IR; Neumann M; Lee VM; Hatanpaa KJ; White CL; Schneider JA; Grinberg LT; Halliday G; Duyckaerts C; Lowe JS; Holm IE; Tolnay M; Okamoto K; Yokoo H; Murayama S; Woulfe J; Munoz DG; Dickson DW; Ince PG; Trojanowski JQ; Mann DM;
Acta Neuropathol; 2007 Jul; 114(1):5-22. PubMed ID: 17579875
[TBL] [Abstract][Full Text] [Related]
34. Pathological tau deposition in Motor Neurone Disease and frontotemporal lobar degeneration associated with TDP-43 proteinopathy.
Behrouzi R; Liu X; Wu D; Robinson AC; Tanaguchi-Watanabe S; Rollinson S; Shi J; Tian J; Hamdalla HH; Ealing J; Richardson A; Jones M; Pickering-Brown S; Davidson YS; Strong MJ; Hasegawa M; Snowden JS; Mann DM
Acta Neuropathol Commun; 2016 Mar; 4():33. PubMed ID: 27036121
[TBL] [Abstract][Full Text] [Related]
35. A quantitative study of the neuropathology of 32 sporadic and familial cases of frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP).
Armstrong RA; Carter D; Cairns NJ
Neuropathol Appl Neurobiol; 2012 Feb; 38(1):25-38. PubMed ID: 21696412
[TBL] [Abstract][Full Text] [Related]
36. Senile onset frontotemporal lobar degeneration with TAR-DNA binding protein 43 proteinopathy primarily presenting with wasteful habits.
Iwasaki Y; Mori K; Ito M; Tatsumi S; Mimuro M; Yoshida M
Psychogeriatrics; 2013 Dec; 13(4):260-4. PubMed ID: 24289467
[TBL] [Abstract][Full Text] [Related]
37. Frontotemporal Dementia: Correlations Between Psychiatric Symptoms and Pathology.
Scarioni M; Gami-Patel P; Timar Y; Seelaar H; van Swieten JC; Rozemuller AJM; Dols A; Scarpini E; Galimberti D; ; Hoozemans JJM; Pijnenburg YAL; Dijkstra AA
Ann Neurol; 2020 Jun; 87(6):950-961. PubMed ID: 32281118
[TBL] [Abstract][Full Text] [Related]
38. Neuropathological heterogeneity in frontotemporal lobar degeneration with TDP-43 proteinopathy: a quantitative study of 94 cases using principal components analysis.
Armstrong RA; Ellis W; Hamilton RL; Mackenzie IR; Hedreen J; Gearing M; Montine T; Vonsattel JP; Head E; Lieberman AP; Cairns NJ
J Neural Transm (Vienna); 2010 Feb; 117(2):227-39. PubMed ID: 20012109
[TBL] [Abstract][Full Text] [Related]
39. Signature laminar distributions of pathology in frontotemporal lobar degeneration.
Ohm DT; Cousins KAQ; Xie SX; Peterson C; McMillan CT; Massimo L; Raskovsky K; Wolk DA; Van Deerlin VM; Elman L; Spindler M; Deik A; Trojanowski JQ; Lee EB; Grossman M; Irwin DJ
Acta Neuropathol; 2022 Mar; 143(3):363-382. PubMed ID: 34997851
[TBL] [Abstract][Full Text] [Related]
40. FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration.
Urwin H; Josephs KA; Rohrer JD; Mackenzie IR; Neumann M; Authier A; Seelaar H; Van Swieten JC; Brown JM; Johannsen P; Nielsen JE; Holm IE; ; Dickson DW; Rademakers R; Graff-Radford NR; Parisi JE; Petersen RC; Hatanpaa KJ; White CL; Weiner MF; Geser F; Van Deerlin VM; Trojanowski JQ; Miller BL; Seeley WW; van der Zee J; Kumar-Singh S; Engelborghs S; De Deyn PP; Van Broeckhoven C; Bigio EH; Deng HX; Halliday GM; Kril JJ; Munoz DG; Mann DM; Pickering-Brown SM; Doodeman V; Adamson G; Ghazi-Noori S; Fisher EM; Holton JL; Revesz T; Rossor MN; Collinge J; Mead S; Isaacs AM
Acta Neuropathol; 2010 Jul; 120(1):33-41. PubMed ID: 20490813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]